INTRODUCTION
Anxiety disorders are common [1] and costly, [2] with lost work-productivity contributing substantially to their total costs and creating dependence on governmental support. [3] [4] [5] [6] They impact work performance by reducing employment opportunities, work functioning, and attendance. Pharmacological treatments can reduce symptoms and improve function, but also cause side effects that can undermine functional improvement. [7] There is growing consensus that in order to optimize treatments, outcome studies should measure both symptomatic and functional recovery, including general quality of life and work performance. [8] Work function studies in patients with panic disorder have documented high unemployment and low healthrelated quality of life; and even those with jobs report low work-productivity. [9, 10] Feeling disabled at work is associated with low ''Quality of Well-Being.'' [11] Most anxiety studies have focused on panic, so information on other anxiety disorders is limited, though anxiety diagnoses in general have been associated with impaired work performance. [12] [13] [14] An epidemiological study [3, 15] also documented a narrowed range of employment opportunities, difficulty changing jobs, and restrictions in hours worked among people with anxiety disorders.
Integrating existing literature is difficult due to the wide range of instruments used, making comparisons across studies and across disorders difficult. [16] Numerous work-function instruments have been validated over the past decade. [17, 18] Most can be used across disorders, but they vary in aspects of work function measured, and some may be better than others in identifying work impairment and tracking improvement for particular disorders.
This study examined self-reported work-productivity in adult patients with anxiety disorders, using four major instruments in wide-spread use at its inception (Work Limitations Questionnaire (WLQ), Endicott Work Productivity Scale (EWPS), Work Productivity and Activity Impairment Questionnaire (WPAI), and Work Performance Scale of the Functional Status Questionnaire (WPS)). Goal one was to examine the impact of anxiety severity on work-related outcomes in an anxiety specialty clinic population. Goal two was to examine psychometric properties (sensitivity, internal reliability, and construct validity) of the four instruments and to assess their relative suitability for use in this population.
METHODS DESIGN AND SAMPLE
We measured self-reported health-related quality of life and workrelated outcomes for patients seeking anxiety treatment, prior to treatment and at 12-week follow-up. Patients seeking evaluation at the University of Michigan Anxiety Disorders Program between February 2002 and June 2005 were recruited and offered a $20 incentive to participate. Entry criteria required presence of an anxiety disorder (generalized anxiety, panic, obsessive-compulsive disorder, or social phobia) in patients who were adult (18 years old) English speakers who worked outside the home at least 20 hr per week for pay. Patients with schizophrenia, substance abuse, dementia, or suicidal ideation were excluded. The study was IRB approved and all subjects provided written, informed consent. Diagnoses were established on the basis of a two-hour clinical interview and consensus review by an interdisciplinary team.
DATA COLLECTION
Data were obtained from questionnaires and medical records. A work survey was mailed to all new patients as a single document containing the four work-productivity questionnaires (106 items), along with the consent document, a postage-free return envelope, and clinical questionnaires assessing symptom profiles and severity. Subjects were asked to return completed materials by mail before evaluation, but were also permitted to complete them at initial visit. Twelve weeks later, subjects with complete baseline data were mailed a follow-up packet containing only quality of life and work performance instruments.
WORK MEASURES
The WLQ [19] covers a two-week time period with 25 items and 4 subscales: (1) ''time management,'' (2) ''physical demands,'' (3) ''mental-interpersonal demands,'' and (3) ''output demands.'' Subscale scores range from 0 (greatest impairment) to 100 (highest possible performance). The WPAI Questionnaire (WPAI, General Version) describes work, classroom, and activity impairment as a result of disease and/or treatment [20, 21] using four subscales: (1) ''percent activity impairment,'' (2) ''percent work time missed,'' (3) ''percent impairment while working,'' and (4) ''final overall work impairment.'' Scores range from 0 to 100% (complete impairment). The EWPS measures work-productivity [22] in various job settings, including self-employment, using 25 items (0-4 scale) to quantify work-related behaviors, feelings, or attitudes over the past week. Item scores are summed to produce a total score with higher values reflecting greater impairment. The Functional Status Questionnaire WPS measures amount of work performed, time worked and breaks per shift, hours worked, accuracy and carefulness of work, healthrelated job changes, and fear of losing job due to health. [23] It uses six items scored on a five-point scale, with low scores reflecting impairment.
Additional job-related questions were included on an investigator-formulated questionnaire to measure overall job satisfaction, length of time on the job, likelihood of choosing the same job again, and type of job (International Standard Classification of Occupations, 1988). Subjective ratings of ''strongly agree'' to ''strongly disagree'' were used to assess the influence of anxiety on job choice and job advancement. [24, 25] Number of work hours missed in the preceding week was included to assess absenteeism.
SEVERITY AND CLINICAL CHANGE MEASURES
The Beck Anxiety Inventory (BAI) [26] was obtained at baseline only, providing a general measure of anxiety severity applicable across diagnoses. Scores can range from 0 to 63 and are categorized as minimal (0-7), mild (8) (9) (10) (11) (12) (13) (14) (15) , moderate (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) , and severe . Clinical improvement in disease severity over the 12-week follow-up was quantified using the Clinical Global Impressions, Global Improvement Scale (CGI-I), patient version. [27] 
ADDITIONAL MEASURES
The SF-36 Health Survey Version 2 (SF-36) was used to assess health-related quality of life. [28] It measures self-perceived concepts of physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality, social function, role limitations due to emotional problems, and mental health. The ''roleemotion'' and ''role-physical'' scales include references to work, and together they function as a broad descriptor of role-functioning. The Sheehan Disability Scale (SDS) [29] provided another general measure of role functioning (3 Likert measures of symptom interference with work, social life, and family/home life).
ANALYSES
The BAI was used to dichotomize patients into high (BAI scores of 16-63) and low (BAI 0-15) severity groups. The two groups were compared on demographic, job, and work-related data using t-tests and w 2 tests. Effect sizes for differences between groups were calculated using Cohen's d.
Patients were separately dichotomized using CCG-I scores (after 12 weeks of treatment) into those who perceived worsening or no change in their anxiety and those who perceived improvement. Separate paired t-tests were used for each group to determine whether the group improved significantly from baseline to follow-up on work-productivity measures. Effect sizes for differences in the change in scale scores between groups were calculated using Cohen's d.
Internal consistency of all multi-item subscales for the WLQ, EWPS, and WPS instruments was assessed using Cronbach's a. Construct validity was assessed using Spearman's rank-order correlation, comparing work-productivity scale scores and the rolefunctioning scales of the SF-36 and the work-performance scale of the SDS.
Missing data from individual questionnaires were handled according to the recommendations of the developers of each questionnaire. Generally, if more than half of the item responses of a particular scale were missing, the scale score was not calculated. For all analyses, differences were considered significant at Pr0.05.
RESULTS
Because of personnel problems, active recruitment was underway during approximately half of the evaluation clinics conducted over the 3-year recruitment span. Because of manpower limitations, not all patients at each evaluation clinic could be approached for consent. We estimate that fewer than 300 of a potential pool of 717 patients were invited to participate, and a proportion of these did not meet age or diagnosis entry criteria. Of those eligible, 159 signed informed consent and 115 met the work requirement at the time of questionnaire completion. Eighty-one of these provided complete baseline data, and 50 provided both baseline and follow-up data.
CHARACTERISTICS OF THE TWO SEVERITY GROUPS
Of the 81 patients included in baseline analyses, 41 were categorized by the BAI as minimal-to-mild in severity and 40 were categorized as moderate-tosevere. Group demographic, illness, and health status data are presented in Table 1 . Groups did not differ in age, race, education, anxiety diagnosis, or physicalrelated health status. The high anxiety group contained more females and demonstrated lower mental-related health status, role physical, and role emotional scale scores, and greater Sheehan disability compared to the low anxiety group.
On work-related measures, the groups did not differ in the type of job, length of time on job, satisfaction with job, or job choice (Table 2 ). However, significantly more patients in the high anxiety group indicated that anxiety impaired their ability to advance in their job.
Group comparisons on work-performance scale scores are presented in Table 3 . The high anxiety group was significantly more impaired than the low anxiety group on the WPS, the WPAI ''percent impairment while at work,'' ''overall work impairment,'' ''percent activity impairment'' subscales, and the WLQ ''output demands,'' ''physical demands,'' and ''interpersonal demands'' subscales. Effect sizes were generally moderate, ranging from 0.36 to 0.73, except for a large anxiety severity effect (0.87) on WPAI-Percent Activity Impairment Due to Health. Three of the four WPAI scores had effect sizes over 0.7, while the four WLQ scales effect sizes were 0.68 or less.
Of the 50 patients with both baseline and follow-up data, 38 improved and 12 did not change or worsened (Table 4 ). The group without symptom improvement showed no changes on any work performance measures. The symptomatically improved group showed mixed results. Many measures showed no change, but three of the four scales of the WPAI (''percent impairment while working,'' ''final overall impairment due to health,'' and ''percent activity impairment due to health'') improved significantly in this group. They also improved significantly on two of the four WLQ subscales (''output demands'' and ''mental interpersonal''). Effect sizes for change score comparisons between groups were generally moderate (Table 4) . Large effect sizes were observed for the WPAI-Percent Activity Impairment due to Health, the WLQ-Output Demands, and the WLQ MentalInterpersonal scale comparisons. The instruments all had good internal consistency, with Cronbach's as as follows: EWPS 5 0.95, WPS 5 0.82, WLQ ''time management'' 5 0.91, ''physical demands'' 5 0.97, ''mental interpersonal'' 5 0.92, and ''output demands'' 5 0.93. Construct validity was assessed by correlating subscales of the work-productivity measures with the role-emotional and role-physical functioning scales of the SF-36, and with the SDS work scale (Table 5 ). The SF-36 role-emotional and the SDS work impairment scales were significantly correlated with all but one of the work-performance instruments and subscales. These correlations were moderate-to-good (r 5 .4-.8). The WLQ ''physical demands'' subscale was significantly correlated with the SF-36 ''role-emotional'' score.
DISCUSSION
These data confirm that patients presenting for treatment in an academic anxiety disorders program have substantial work impairment and that greater work performance impairment is reported by those with higher anxiety severity. Similar relationships have been documented in other studies, for both depression and anxiety, examining work performance and attendance, using the WLQ, the Stanford Presenteeism Scale, and two single item scales measuring presenteeism days and inefficiency days. [12] The presence of an anxiety disorder is also associated with less accomplished at work. [3] Based on the WLQ, anxiety has a significant influence on interpersonal relationships at work as well as work output. The general measure WPAI confirms this association with significant findings based on Overall Work Impairment due to Health and Percent Impairment While at Work due to Health scale scores.
The WLQ and the WPAI demonstrated the most consistent psychometric properties of the four instruments examined. Both provide multiple subscales and most demonstrated acceptable validity. For example, there were significant differences on WLQ ''output demands,'' ''physical demands,'' and ''mental interpersonal demands'' scales based on comparison by anxiety severity, with better work performance associated with lower anxiety. Symptom severity effects on WPAI measured impairment have also been reported by others. [12] Our moderate-to-large effect sizes for all comparisons based on severity support the validity of these scales.
We did not find anxiety group differences in WPAI ''percent work time missed due to health'' and the WLQ ''physical demands'' scale. This suggests that high anxiety may not lead to absences as often as physical illnesses, though impaired functioning while at work was clearly present in this group.
The WLQ demonstrated acceptable internal consistency. The WPAI uses single item scales so internal consistency is not relevant. Two of four WLQ scales (''output demands'' and ''mental interpersonal'') and three of four WPAI scales (all but ''percent time missed due to health'') demonstrated sensitivity to changes in perceived clinical condition, with significant improvement in work function over the twelve week follow-up period in patients who perceived improvement in their disorder. Effect sizes for improvement group comparisons on symptom change scores were moderate to large, further confirming their ability to detect change.
The WPS and the EWPS did not function as effectively as the WLQ and the WPAI. Both showed good internal consistency, and the WPS was better able to distinguish work performance based on anxiety severity than the EWPS; but neither instrument was sensitive to symptom change in patients who improved, based on change within group comparisons.
Based on correlation analyses with role functioning and SDS-work scales, all instruments tested were valid in this anxious population. However, to be useful in comparative studies or clinical practice, instruments should be able to discriminate between various levels of disease severity. The WPAI and WLQ scales demonstrated this ability; the EWPS and WPS did not. The WPAI provides a good general assessment of time missed from work and percent impairment using only 6 questions, which tracked both anxiety severity and improvement with treatment. It provides a good, brief instrument when a general measure is sufficient. When more detailed, domain specific work performance data is needed, the 25 item WLQ can be used, alone or in conjunction with the WPAI., to provide a more comprehensive picture of work functioning.
LIMITATIONS
We enrolled only a subset of patients seeking treatment and do not have good data to document how representative these were of our total clinic population, though we have no evidence of any systematically biasing factors in our recruitment efforts. We also recruited only from an academic anxiety specialty clinic. Further work is needed to determine the generalizability of our results. We included only patients with anxiety disorders and did not document the presence of physical illness. We therefore cannot evaluate the impact of concurrent physical illness on work performance in these anxious patients, and cannot compare them to patients with other psychiatric disorders. We also only included patients who had jobs outside their homes. Since anxiety patients have high rates of nonparticipation in the work force, [3] we likely underestimated the true impact of anxiety on work function.
Test-retest reliability was not assessed as part of the psychometric analysis. We were focused on the association of clinical outcomes with work performance, so we used a 12 week follow-up period to capture significant clinical improvement, and predicted clinically-related change in work performance measures. Assessment of test-retest stability would require a different design and a much shorter reassessment period.
CONCLUSION
Work performance was measured using four work performance instruments in a clinic sample of anxiety disorder patients. Greater illness severity was associated with greater impairment in work-performance. Work performance improved with symptom improvement. For this population, we recommend the WPAI as a brief, general measure of work function and the WLQ when a more detailed, domain specific instrument is needed, as both showed good psychometric performance, sensitivity to illness severity, and sensitivity to change with symptomatic improvement.
